Alopecia Associated with the Use of Semaglutide and Tirzepatide: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS) from 2022 to 2023.
JEADV Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要